SLC5A2 and hydrops fetalis: The occurrence of acute HF hospitalizations exclusively in the DBCM group and the more frequent NYHA class improvement in patients receiving SGLT2 inhibitors suggest that early identification and tailored therapy may improve symptoms and reduce adverse events.